embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

Embecta to buy Owen Mumford for up to $201M

The planned purchase would allow Embecta to serve patients outside of diabetes care.

embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting

Embecta agrees to acquire Owen Mumford

Embecta has agreed to acquire Owen Mumford Holdings for up to $172.6m, enhancing its global presence in drug delivery technologies.The post Embecta agrees to acquire Owen Mumford appeared first on Hospital Management.

Embecta to buy auto-injector maker Owen Mumford for $199.4M

Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited. Owen Mumford, a privately held, UK-based company, develops and manufactures medical devices and drug delivery technologies. Embecta, the former BD Diabetes business, agreed to acquire Owen Mumford with an upfront cash payment of approximately $133 million (£100 million). The deal also includes an additional $66.4 million (£…

Embecta to acquire Owen Mumford

PARSIPPANY, N.J. – Embecta Corp. (“Embecta”), a global leader in diabetes care technology, announced Thursday that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million. Under the terms of the agreement, embecta will acquire Owen Mumford for an upfro…